Literature DB >> 29736216

Rab5a suppresses autophagy to promote drug resistance in cancer cells.

Wenxia Xu1, Qiqi Shi2, Xiaoling Qian3, Bingluo Zhou2, Jinye Xu2, Liyuan Zhu1, Lifeng Feng1, Hongchuan Jin1, Xian Wang2.   

Abstract

Cancers are huge problems that need to be investigated thoroughly. Rab5a plays an important part in the regulation of intracellular membrane trafficking. However, its role in cancer and autophagy has not been fully determined. In this study, we analyzed the correlation between Rab5a expression and patients' prognosis and then explored the effect of Rab5a knockdown on different cell lines using western blotting and fluorescence. Our results showed that up-regulated Rab5a positively correlated with the prognosis of gastric cancer patients. After knocking down Rab5a, mTOR activity was inhibited and autophagy flux increased. We also found that in our cisplatin-resistant cells, knockdown of Rab5a activated autophagy via mTOR pathway and could reverse drug resistance while overexpression of Rab5a in drug sensitive cells increased drug tolerance. In conclusion, our study demonstrates that Rab5a can suppress autophagy through mTOR and promote drug resistance in gastric cancer cells.

Entities:  

Keywords:  Rab5a; autophagy; cancer; chemoresistance; mTOR

Year:  2018        PMID: 29736216      PMCID: PMC5934582     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  27 in total

Review 1.  Rab proteins as membrane organizers.

Authors:  M Zerial; H McBride
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

2.  Rab5 is necessary for the biogenesis of the endolysosomal system in vivo.

Authors:  Anja Zeigerer; Jerome Gilleron; Roman L Bogorad; Giovanni Marsico; Hidenori Nonaka; Sarah Seifert; Hila Epstein-Barash; Satya Kuchimanchi; Chang Geng Peng; Vera M Ruda; Perla Del Conte-Zerial; Jan G Hengstler; Yannis Kalaidzidis; Victor Koteliansky; Marino Zerial
Journal:  Nature       Date:  2012-05-23       Impact factor: 49.962

Review 3.  Autophagy and tumorigenesis.

Authors:  Nan Chen; Jayanta Debnath
Journal:  FEBS Lett       Date:  2009-12-24       Impact factor: 4.124

4.  Phenoxodiol Increases Cisplatin Sensitivity in Ovarian Clear Cancer Cells Through XIAP Down-regulation and Autophagy Inhibition.

Authors:  Morikazu Miyamoto; Masashi Takano; Tadashi Aoyama; Hiroaki Soyama; Hiroki Ishibashi; Kento Kato; Hideki Iwahashi; Kazuki Takasaki; Mika Kuwahara; Hiroko Matuura; Takahiro Sakamoto; Tomoyuki Yoshikawa; Kenichi Furuya
Journal:  Anticancer Res       Date:  2018-01       Impact factor: 2.480

Review 5.  Autophagy: The spotlight for cellular stress responses.

Authors:  Palaniyandi Ravanan; Ida Florance Srikumar; Priti Talwar
Journal:  Life Sci       Date:  2017-09-01       Impact factor: 5.037

6.  YY1-MIR372-SQSTM1 regulatory axis in autophagy.

Authors:  Lifeng Feng; Yanning Ma; Jie Sun; Qi Shen; Leiming Liu; Haiqi Lu; Faliang Wang; Yongfang Yue; Jiaqiu Li; Shenjie Zhang; Xiaoying Lin; Jue Chu; Weidong Han; Xian Wang; Hongchuan Jin
Journal:  Autophagy       Date:  2014-06-11       Impact factor: 16.016

7.  MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.

Authors:  Bowen Li; Weizhi Wang; Zheng Li; Zheng Chen; Xiaofei Zhi; Jianghao Xu; Qing Li; Lu Wang; Xiaoxu Huang; Linjun Wang; Song Wei; Guangli Sun; Xuan Zhang; Zhongyuan He; Lu Zhang; Diancai Zhang; Hao Xu; Wael El-Rifai; Zekuan Xu
Journal:  Cancer Lett       Date:  2017-09-28       Impact factor: 8.679

8.  PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.

Authors:  Jin Zeng; Wei Liu; Yi-Zeng Fan; Da-Lin He; Lei Li
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

9.  Active autophagy in the tumor microenvironment: A novel mechanism for cancer metastasis.

Authors:  Yinghua Xu; Xiaoping Xia; Hongming Pan
Journal:  Oncol Lett       Date:  2012-11-07       Impact factor: 2.967

10.  Combined Inhibitions of Glycolysis and AKT/autophagy Can Overcome Resistance to EGFR-targeted Therapy of Lung Cancer.

Authors:  Mingtong Ye; Sufan Wang; Ting Wan; Rui Jiang; Yun Qiu; Lei Pei; Nengzhi Pang; Yuanling Huang; Yufeng Huang; Zhenfeng Zhang; Lili Yang
Journal:  J Cancer       Date:  2017-10-17       Impact factor: 4.207

View more
  5 in total

Review 1.  Facing Cell Autophagy in Gastric Cancer - What Do We Know so Far?

Authors:  Ting Xiu; Qie Guo; Fan-Bo Jing
Journal:  Int J Gen Med       Date:  2021-05-03

2.  HOTTIP Predicts Poor Survival in Gastric Cancer Patients and Contributes to Cisplatin Resistance by Sponging miR-216a-5p.

Authors:  Rui Zhao; Xin Zhang; Yanli Zhang; Yaping Zhang; Yongmei Yang; Yue Sun; Xin Zheng; Ailin Qu; Yvette Umwali; Yi Zhang
Journal:  Front Cell Dev Biol       Date:  2020-05-08

Review 3.  The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe?

Authors:  Jing-Li Xu; Li Yuan; Yan-Cheng Tang; Zhi-Yuan Xu; Han-Dong Xu; Xiang-Dong Cheng; Jiang-Jiang Qin
Journal:  Front Cell Dev Biol       Date:  2020-12-03

4.  LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/miR-324-3p-SIRT5 axis in lung adenocarcinoma.

Authors:  Jie Wu; Chunlei Zheng; Yizhe Wang; Zichang Yang; Ce Li; Wanxia Fang; Yue Jin; Kezuo Hou; Yang Cheng; Jianfei Qi; Xiujuan Qu; Yunpeng Liu; Xiaofang Che; Xuejun Hu
Journal:  Biomark Res       Date:  2021-01-30

Review 5.  Endocytosis: a pivotal pathway for regulating metastasis.

Authors:  Imran Khan; Patricia S Steeg
Journal:  Br J Cancer       Date:  2020-12-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.